Breaking News Instant updates and real-time market news.

DCPH

Deciphera

$23.73

-0.09 (-0.38%)

04:55
04/30/19
04/30
04:55
04/30/19
04:55

Deciphera management to meet with SunTrust

Meeting to be held in Mid-Atlantic on April 30 hosted by SunTrust.

  • 30

    Apr

  • 07

    May

  • 30

    May

  • 31

    May

DCPH Deciphera
$23.73

-0.09 (-0.38%)

01/03/19
PIPR
01/03/19
NO CHANGE
PIPR
Piper sees Alexion, Biogen as potential targets after Celgene buyout
Piper Jaffray analyst Christopher Raymond remains "bullish on biotech" in the wake the announced acquisition of Celgene (CELG) by Bristol-Myers Squibb (BMY) for $74B in cash and stock, representing a 54% premium from yesterday's close. In a research note titled "Bristol for CELG - In Retrospect, it Makes Perfect Sense," Raymond says the market is likely to ask "who's next?" Among large-caps, Alexion Pharmaceuticals (ALXN) and Biogen (BIIB) would seem to make sense as potential targets, as well as BioMarin (BMRN), Raymond writes. And while any smid cap could likely be seen as a take-out candidate, Aimmune Therapeutics (AIMT), Deciphera Pharmaceuticals (DCPH) and Rigel Pharmaceuticals (RIGL) "in particular could make sense to any strategic buyer," adds the analyst.
03/06/19
PIPR
03/06/19
NO CHANGE
PIPR
Departure of Gottlieb brings some biopharma uncertainty, says Piper Jaffray
Piper Jaffray remains "largely bullish" on the biopharma sector but acknowledges a "new and unexpected" source of uncertainty now with the announced departure of FDA commissioner Scott Gottlieb, analysts led by Christopher Raymond tell investors in a research note. With a track record of favoring innovation and pushing for increased regulatory efficiency while also advocating for more competition, Dr. Gottlieb was about as "market friendly, patient focused and industry friendly as one could have hoped," Piper writes. The firm adds that while it has no reason to believe the next commissioner "will be quite as radical and potentially damaging to the industry," it does think investors would do well to watch the selection process very closely.
03/12/19
PIPR
03/12/19
NO CHANGE
PIPR
Biopharma stocks should be up sharply on Sharpless selection, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond said he expects biopharma stocks to be up sharply on news that former National Cancer Institute director Ned Sharpless will be named acting FDA commissioner. The biotech sector "experienced a swoon of sorts" since Scott Gottlieb announced his departure, but with the announcement of Gottlieb's favored choice as successor Raymond believes the FDA will remain "on its current industry-friendly and efficiency driven trajectory," the analyst tells investors.
03/14/19
PIPR
03/14/19
NO CHANGE
Target $50
PIPR
Overweight
Deciphera development of ripretinib 'progressing nicely', says Piper Jaffray
Piper Jaffray analyst Christopher Raymond kept his Overweight rating and $50 price target on Deciphera after its in-line Q4 results, saying the company's development of ripretinib is progressing nicely with ongoing phase 3 enrollment in INTRIGUE study and results for INVICTUS study expected later this year. The analyst remains positive on the shares given the company's "catalyst-rich" second half of the year on tap.

TODAY'S FREE FLY STORIES

URBN

Urban Outfitters

$20.98

0.12 (0.58%)

16:09
08/20/19
08/20
16:09
08/20/19
16:09
Hot Stocks
Breaking Hot Stocks news story on Urban Outfitters »

Urban Outfitters down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 25

    Sep

SCSC

Scansource

$31.55

-0.24 (-0.75%)

16:09
08/20/19
08/20
16:09
08/20/19
16:09
Earnings
Scansource sees Q1 non-GAAP EPS 70c-75c, consensus 35c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 19

    Sep

URBN

Urban Outfitters

$20.97

0.11 (0.53%)

16:09
08/20/19
08/20
16:09
08/20/19
16:09
Hot Stocks
Urban Outfitters says total inventory increased by $64.4M as of July 31 »

As of July 31, total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 25

    Sep

URBN

Urban Outfitters

$20.96

0.1 (0.48%)

16:08
08/20/19
08/20
16:08
08/20/19
16:08
Hot Stocks
Urban Outfitters reports Q2 comparable retail segment net sales down 3% »

Q2 comparable retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 25

    Sep

URBN

Urban Outfitters

$20.92

0.06 (0.29%)

16:07
08/20/19
08/20
16:07
08/20/19
16:07
Earnings
Urban Outfitters reports Q2 EPS 61c, consensus 58c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 25

    Sep

SCSC

Scansource

$31.85

0.06 (0.19%)

16:06
08/20/19
08/20
16:06
08/20/19
16:06
Earnings
Scansource reports Q4 non-GAAP EPS 71c, consensus 43c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 19

    Sep

REI

Ring Energy

$1.66

-0.07 (-4.06%)

16:06
08/20/19
08/20
16:06
08/20/19
16:06
Earnings
Ring Energy releases mid-Q3 operations update »

Ring Energy released a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYBX

Synlogic

$3.45

-1.37 (-28.42%)

16:06
08/20/19
08/20
16:06
08/20/19
16:06
Downgrade
Synlogic rating change  »

Synlogic downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CREE

Cree

$58.36

0.08 (0.14%)

16:03
08/20/19
08/20
16:03
08/20/19
16:03
Earnings
Cree sees Q1 adjusted EPS (7c)-(3c), consensus 15c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

MOGO

Mogo Finance

$2.60

(0.00%)

16:03
08/20/19
08/20
16:03
08/20/19
16:03
Hot Stocks
Mogo Finance surpasses 900,000 member milestone »

Mogo announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CREE

Cree

$58.35

0.07 (0.12%)

16:01
08/20/19
08/20
16:01
08/20/19
16:01
Earnings
Cree reports Q4 adjusted EPS 11c, consensus 10c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

BCRX

BioCryst

$2.70

0.025 (0.94%)

16:00
08/20/19
08/20
16:00
08/20/19
16:00
Conference/Events
BioCryst management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

15:55
08/20/19
08/20
15:55
08/20/19
15:55
Conference/Events
Cantor Fitzgerald tech analyst to hold an analyst/industry conference call »

Technology & Business…

LZB

La-Z-Boy

$30.73

-1.14 (-3.58%)

15:42
08/20/19
08/20
15:42
08/20/19
15:42
Options
La Z Boy options imply 11.9% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 27

    Aug

MAS

Masco

$39.07

0.26 (0.67%)

15:41
08/20/19
08/20
15:41
08/20/19
15:41
Periodicals
Bain, AIP said bidding on Masco cabinet unit, Bloomberg reports »

The unit is said to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALC

Alcon

$62.41

0.62 (1.00%)

15:34
08/20/19
08/20
15:34
08/20/19
15:34
Options
Alcon options imply 5.4% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 04

    Sep

  • 09

    Sep

TSLA

Tesla

$225.57

-1.18 (-0.52%)

, WMT

Walmart

$112.40

-1.36 (-1.20%)

15:28
08/20/19
08/20
15:28
08/20/19
15:28
Periodicals
Breaking Periodicals news story on Tesla, Walmart »

Walmart sues Tesla over…

TSLA

Tesla

$225.57

-1.18 (-0.52%)

WMT

Walmart

$112.40

-1.36 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 15

    Sep

  • 23

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

VTGN

VistaGen Therapeutics

$0.62

(0.00%)

15:26
08/20/19
08/20
15:26
08/20/19
15:26
Hot Stocks
VistaGen not 'a one product' company, says CEO »

VistaGen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

JKHY

Jack Henry

$140.60

-0.91 (-0.64%)

15:19
08/20/19
08/20
15:19
08/20/19
15:19
Options
Jack Henry options imply 5.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 11

    Sep

  • 12

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
08/20/19
08/20
15:17
08/20/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
08/20/19
08/20
15:16
08/20/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTGN

VistaGen Therapeutics

$0.62

(0.00%)

15:11
08/20/19
08/20
15:11
08/20/19
15:11
Hot Stocks
VistaGen's Singh says partnerships in large markets outside U.S. make most sense »

VistaGen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

SABR

Sabre

$23.74

-0.19 (-0.79%)

15:10
08/20/19
08/20
15:10
08/20/19
15:10
Hot Stocks
Sabre to challenge DOJ lawsuit seeking to block Farelogix acquisition »

Sabre Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTE

PolarityTE

$5.05

-0.14 (-2.70%)

15:09
08/20/19
08/20
15:09
08/20/19
15:09
Recommendations
PolarityTE analyst commentary at Cantor Fitzgerald »

PolarityTE's patent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 21

    Aug

  • 09

    Sep

STRL

Sterling Construction

$11.55

0.31 (2.76%)

15:06
08/20/19
08/20
15:06
08/20/19
15:06
Conference/Events
Sterling Construction management to meet with KeyBanc »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.